The sensitivity of GPC3 combined with AFP in diagnosing HCC was the highest among the three combined tests, suggesting that this combination may be more suitable for early screening of HCC to reduce the risk of missed diagnosis. The gene discussed is GPC3; the disease is hepatocellular carcinoma.